02/20/2026
🌟 Survivorship Team Highlight! 🌟
We’re proud to spotlight Vanessa Shehu, who presented at the Multidisciplinary Head & Neck Cancer Symposium.
Her presentation:
🔬 Evaluation of To***co and Alcohol Usage on the Efficacy of Anti-PD-1 mAb Therapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck (R/M HNSCC)
Her research explores how lifestyle-related risk factors may influence immunotherapy response, contributing to more personalized treatment strategies and improved outcomes for patients with recurrent and metastatic head and neck cancer.
Join us in celebrating this important contribution to multidisciplinary cancer care! 👏